Rep. Matt Gaetz

This bill limits FY2024 funding for the Centers for Disease Control and Prevention for HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis prevention.

Maddy summaryHR 1961 sets a funding cap of $448,805,000 for the Centers for Disease Control and Prevention's Immunization and Respiratory Diseases program during fiscal year 2024. This bill directly limits the amount of federal funds available to this specific CDC division, preventing it from spending more than the specified amount. The provision applies only to this particular program within the Department of Health and Human Services and does not alter the program's activities or scope. This is a procedural budget measure, not a substantive policy change.

Maddy summaryThis bill sets a spending cap of $155,250,000 for the Health Resources and Services Administration's (HRSA) program management within the Department of Health and Human Services for fiscal year 2024. It directly affects HRSA's administrative operations by limiting the funds available for managing its programs, including community health centers and maternal health initiatives. The provision prevents the use of any funds exceeding this specific amount for HRSA's program management activities during FY2024.

Maddy summaryThis bill (HR 1959) sets a strict spending cap of $286,479,000 for the Health Resources and Services Administration's (HRSA) Family Planning program within the Department of Health and Human Services (HHS) for fiscal year 2024. It directly affects the HRSA Family Planning program by limiting federal funding available for its operations during FY2024. The key mechanism is a statutory provision that overrides other laws to prevent spending above this specific dollar amount. This is a concrete budget restriction, not a change to program eligibility or services.

Maddy summaryHR 1958 imposes a spending cap of $317,794,000 on funding for the Health Resources and Services Administration's (HRSA) Rural Health program for fiscal year 2024. This bill directly affects the HRSA Rural Health program by restricting its budget authorization for that specific fiscal year. The key provision is a statutory limit preventing the program from receiving more than the specified amount, regardless of other funding authorizations. This change applies solely to the fiscal year 2024 funding allocation for rural health services under HRSA.

Maddy summaryThis bill sets a strict spending cap of $115,193,000 for the Health Resources and Services Administration's (HRSA) Health Care Systems program in fiscal year 2024. It directly affects federal funding for HRSA's healthcare programs that support underserved communities, including rural clinics and community health centers. The key provision is a legal limit preventing any increase above this specific amount for the designated program. This is a budgetary restriction, not a new policy or program.

This bill limits FY2024 funding for the Health Resources and Services Administration for the Ryan White HIV/AIDS Program. (This program provides federal funds to eligible metropolitan areas, states, and local community-based organizations to assist with health care costs and support services for individuals and families affected by HIV/AIDS.)

Maddy summaryThis bill sets a strict annual spending cap of $1.909 billion for the National Institutes of Health (NIH) Office of the Director for fiscal year 2024. It directly affects the NIH Office of the Director by limiting its available funds to this specific amount, overriding any other funding provisions. The key mechanism is a direct dollar limit on appropriations, preventing the use of funds beyond this threshold for the specified NIH office. This is a procedural budgetary restriction, not a policy change affecting public programs or services.

Maddy summaryThis bill sets a spending limit of $162.99 million for the National Institute of Nursing Research (NINR) within the National Institutes of Health (NIH) for fiscal year 2024. It directly affects the NINR by restricting the amount of federal funds it can use during that fiscal year. The key mechanism is a specific dollar cap that prevents the NINR from accessing funds exceeding this amount, regardless of other funding authorizations. The bill does not alter NINR programs or research priorities, only establishing a maximum budget level for FY2024.

This bill limits FY2024 funding for the National Center for Advancing Translational Sciences. (The center works with patient organizations, researchers, and clinicians to develop tools, technologies, and approaches to advance biomedical research and treatments.)